D57.3 – Sickle Cell Trait: Causes & Info
D57.3 is the ICD-10 code for sickle cell trait. It describes a genetic carrier state in which one abnormal haemoglobin gene is inherited, usually causing no severe symptoms.
Things worth knowing about "D57.3"
D57.3 is the ICD-10 code for sickle cell trait. It describes a genetic carrier state in which one abnormal haemoglobin gene is inherited, usually causing no severe symptoms.
What is D57.3 – Sickle Cell Trait?
The ICD-10 code D57.3 refers to the sickle cell trait, also known as the sickle cell carrier state. Individuals with this condition carry one mutated copy of the beta-globin gene, resulting in the production of both normal haemoglobin A (HbA) and abnormal haemoglobin S (HbS). They are heterozygous carriers and generally do not develop the severe form of sickle cell disease.
Causes and Genetics
Sickle cell trait results from a point mutation in the beta-globin gene located on chromosome 11. This mutation causes a single amino acid substitution (glutamic acid replaced by valine), leading to the formation of haemoglobin S.
- Heterozygous individuals (HbAS) carry one normal and one mutated gene copy.
- If both parents are carriers, there is a 25% chance per pregnancy that the child will inherit the homozygous sickle cell disease (D57.0 or D57.1).
- The trait is most prevalent in populations from sub-Saharan Africa, the Mediterranean region, the Middle East, and parts of India, where malaria has historically been endemic.
Symptoms and Clinical Course
Most carriers of the sickle cell trait live entirely symptom-free lives. However, under certain conditions, complications may occur:
- Extreme physical exertion (e.g., elite sports) may in rare cases trigger muscle breakdown (rhabdomyolysis).
- Low oxygen environments (e.g., high altitudes or general anaesthesia) may increase sickling of red blood cells.
- A slightly elevated risk of urinary tract infections and blood in the urine (haematuria) has been reported.
- Carriers are generally not anaemic and have a normal life expectancy.
Diagnosis
Sickle cell trait is identified through laboratory testing:
- Haemoglobin electrophoresis or HPLC (high-performance liquid chromatography): detects both HbA and HbS in the blood.
- Molecular genetic testing: confirms the mutation in the beta-globin gene.
- Newborn screening: many countries include sickle cell screening in their routine newborn programmes.
Management and Counselling
Since D57.3 does not typically represent a disease requiring medical treatment, the focus is on information and prevention:
- Genetic counselling: Carrier couples should be informed about the inheritance risk, particularly when planning a family.
- Patient education: Carriers should be aware of potential risk situations such as high-altitude travel, intense physical activity, and anaesthesia.
- Sports medicine guidance: Elite athletes with sickle cell trait should receive appropriate medical supervision.
- Prenatal diagnosis may be offered to at-risk couples during pregnancy.
Distinction from Sickle Cell Disease
It is essential to differentiate sickle cell trait (D57.3) from sickle cell disease (e.g., D57.0 – sickle cell anaemia with crisis, or D57.1 – sickle cell anaemia without crisis). While carriers rarely experience symptoms, patients with the full disease suffer from severe pain crises, organ damage, and a reduced life expectancy.
References
- World Health Organization (WHO): Sickle-cell disease and other haemoglobin disorders. Fact Sheet, 2023. Available at: https://www.who.int
- German Institute of Medical Documentation and Information (DIMDI): ICD-10-GM Version 2024, Chapter III – D57.3 Sickle cell trait.
- Rees D.C., Williams T.N., Gladwin M.T.: Sickle-cell disease. The Lancet, 376(9757):2018-2031, 2010.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryAdaptation hormone status
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: D57.3